Abstract:BACKGROUND It has been recently reported that inflammatory mechanisms play an important role in in-stent restenosis (ISR) processes. Inflammatory factors after percutaneous coronary intervention (PCI) for dynamic monitoring can probably predict ISR. Functional polymorphisms in the promoter region of genes coding for inflammatory factors might be important for determining the magnitude of the inflammatory response. Thus, in the present study, we aimed to investigate the serial changes in serum interleukin-6 (IL-6) levels before and after PCI and the relationship between the -572C/G polymorphism in the promoter region of the IL-6 gene and ISR. We also discussed genetic polymorphisms in the inflammatory response to PCI. METHODS A total of 437 patients who successfully underwent bare metal stent (BMS) implantation with a follow-up angiography were divided into an ISR group (n = 166) and a non-ISR (NISR) group (n = 271). The IL-6 gene promoter polymorphism at position -572 was determined by restricted fragment length polymorphism using the polymerase chain reaction (PCR-RFLP) method. The serum IL-6 levels before and one day, five days and 180 days after PCI were determined by the radioimmunoassay method. RESULTS ISR patients showed higher IL-6 serum levels than NISR patients before PCI ((324.42 ± 28.14) ng/L vs. (283.22 ± 47.30) ng/L, P < 0.001), and one day post-PCI IL-6 serum levels in the ISR group also showed a significantly higher level than in the NISR group (P < 0.001). Increased IL-6 after PCI persisted at a statistically significant level throughout the study in ISR patients, whereas IL-6 levels had normalized five days after the procedure in NISR patients. One day post-PCI serum IL-6 level was the most accurate marker for diagnosis of ISR, the area under the ROC curve being 0.927 (95%CI 0.878 - 0.977). The cut-off value for IL-6 to predict ISR was over 355.50 ng/L, with a sensitivity of 0.968 and a specificity of 0.865. There were no significant differences in frequencies of -572 genotype and allele between the two groups (P > 0.05). One day post-PCI IL-6 serum levels in patients with the G allele was significantly higher than in patients without the G allele ((366.99 ± 49.37) ng/L vs. (347.20 ± 55.30) ng/L, P < 0.05). In the ISR group, one day post-PCI serum levels of IL-6 in patients with the G allele was also significantly higher than that in patients without the G allele ((405.67 ± 26.56) ng/L vs. (375.69 ± 38.81) ng/L, P < 0.05). Multivariate Logistic regression analysis revealed positive correlations between male gender, one day post-PCI serum levels of IL-6, the pre-PCI degree of stenosis, the length of the target lesion stenosis, and restenosis; and there were negative correlations between the stent diameter, the diameter of the reference vessel before stent implantation and restenosis. CONCLUSIONS IL-6 is an early post-PCI inflammatory cytokine, and one day post-PCI serum IL-6 level is an independent risk factor for restenosis. The frequencies of IL-6 gene -572 genotype and allele are not different between patients with and without ISR in a Chinese Tianjin Han population, but carrying the IL-6 -572G allele is likely to increase an individual's susceptibility to ISR by promoting serum IL-6 levels.

Heme-oxygenase promoter microsatellite polymorphism and inflammatory response to coronary artery bypass surgery

Association Between Polymorphisms of Inflammatory Factor Genes and Coronary Heart Disease

Investigation of the Underlying Hub Genes and Mechanisms of Reperfusion Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery by Integrated Bioinformatic Analyses.

Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis

Prospective Reassessment of the Association Between Pro-Inflammatory Factors and Prognosis after On-Pump Cardiac Surgery.

Gene theory-based intervention: the effect of up-regulating microsatellite polymorphism in heme oxygenase-1 gene promotor

Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter is Associated with Restenosis after Percutaneous Coronary Intervention

Association of Heme Oxygenase-1 Gene Rs2071746 Polymorphism with Vascular Outcomes in Patients with Atherosclerotic Stroke

High mobility group box 1 gene polymorphism is associated with the risk of postoperative atrial fibrillation after coronary artery bypass surgery

Interleukin-6 and Rs1800796 Locus Single Nucleotide Polymorphisms in Response to Hypoxia/reoxygenation in Hepatocytes

Association Between Coronary Heart Disease and Heme Oxygenase-1 Promoter Region Polymorphism and the Influence of the Level of Serum Bilirubin

Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.

Long-term monocyte activation after coronary artery bypass grafting: an exploratory prospective observational study

Association between heme oxygenase-1 gene promoter polymorphism and the susceptibility of human disease

Association Between Hmox-1 Genotype and Cardiac Function During Exercise

The Investigation of Lectin-Like Oxidized LDL Receptor 1 (LOX-1) K167N Polymorphism, Inflammation, and Lipid Status in Patients with Coronary Artery Bypass Grafting

Cardiac Inflammatory Response after Coronary Artery Bypass Grafting

Heme oxygenase-1, mean platelet volume and coronary heart disease: a correlation analysis

C-reactive Protein (+1444C>T) Polymorphism Influences CRP Response Following a Moderate Inflammatory Stimulus.

Heme Oxygenase-1 Microsatellite Polymorphism and Haplotypes Are Associated with the Development of Acute Respiratory Distress Syndrome.

Serum Heme Oxygenase-1 Predicts Clinical Outcome and Hemorrhagic Transformation after Acute Ischemic Stroke